Biomarker test for bacterial infection in newborns
Part of Genetic & congenital, Infections clinical trials.
This trial tests a new biomarker (T6A) to detect bacterial infections in newborn babies. It aims to help doctors diagnose infections faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a newborn baby needing blood tests for possible bacterial infection
- Your doctor thinks you might have a bacterial infection
- Your parents or caregivers give written permission for you to join
- You are not currently receiving any antibiotic treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a faster way to check premature babies for infection using a small blood sample taken shortly after birth. It aims to help doctors detect and treat infections earlier.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This trial is testing a new tool that uses artificial intelligence and biomarkers (substances in your blood) to help doctors recognize sepsis earlier. If you have been diagnosed with sepsis or are suspected of having it, this study may help improve how quickly and accurately it's detected.
This study looks at two simple blood tests (CBC and lactate) in newborns with signs of infection. These tests may help doctors find sepsis faster and guide treatment.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.